Progress Update on the LTA!
Last week was a big week for the Lymphedema Treatment Act! Cosponsor Update: We gained 7 House cosponsors in one week! They are: Coffman (R-CO-6), Hanabusa (D-HI-1), Sarbanes (D-MD-3),
Last week was a big week for the Lymphedema Treatment Act! Cosponsor Update: We gained 7 House cosponsors in one week! They are: Coffman (R-CO-6), Hanabusa (D-HI-1), Sarbanes (D-MD-3),
This week, we ask that you contact the following House leadership offices that serve on the two House Committees that have jurisdiction over our bill. A phone script, sample Tweet,
You can increase support for the Lymphedema Treatment Act by meeting with your members of Congress at a nearby district office! In-person meetings are the single most effective way to
Want to hone your advocacy skills? We have three, free recorded webinars available via the Advocacy Training page of our website. Ever wonder what the history of the Lymphedema Treatment
Spending time with friends and family this summer, and perhaps traveling to new places, presents a great opportunity to spread awareness and knowledge about lymphedema and the Lymphedema Treatment Act!
Over the last few years we have collected over 500 patient and caregiver stories through our My Lymphedema Story campaign. These stories are shared with members of Congress and their
Thanks to the great work of our Maryland advocates, while simultaneously working for passage of the LTA they have succeeded in passing a Maryland lymphedema treatment bill! This state law
Thanks to the calls, emails and outreach of many, the LTA has reached the unbelievable milestone of 403 cosponsors! That’s an incredible 75% of Congress, but we can’t let up
In addition to our annual Lymphedema Lobby Days, where scores of advocates from around the country travel to DC to meet with over 200 offices, our board members make small
Join our email list to learn about
changes to insurance coverage, advocacy actions,
new educational materials and more.
Subscribers receive approximately
one email per week with information
from both of our organizations.

